Acquisition of 100% of the equity share capital of Gland Pharma USA Inc. , a wholly-owned step down subsidiary of the Company, from Gland Pharma International Pte. Ltd, a wholly-owned subsidiary of the Company
Ask the chart: “Has this stock recovered from similar drawdowns before?”
AI equity note (bull/bear, numbers, sources) — coming soon
Management guidance consistency — coming soon
Latest filings
NSE announcements · newest firstOutcome of Board Meeting held on September 13, 2026.
Allotment of 44,193 Equity Shares on exercise of ESOPs
Options to purchase securities
Board comments on fines levied by the Exchanges
Key MetricsFull financials →
Financials are unavailable right now.
Shareholding Pattern
Shareholding is unavailable right now.
Peer Comparison
Peer comparison is unavailable right now.
Forensic Flags
Forensic checks are unavailable right now.